| Announce Date | 11/14/2025 |
| EPS Normalized Actual | $-0.86083 (Miss by $-0.94083) |
| EPS GAAP Actual | $-0.86083 (Miss by $-0.94083) |
| Revenue Actual | $0.0358489B |
| Revenue Surprise | Beat by $35.8489M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $-0.345 |
| EPS GAAP Estimate | $-0.345 |
| Revenue Estimate | $0.034298B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2027 | 0.5 | 0.08 | 0.49912 | 0.50088 | 1 |
| Dec 2026 | 0 | INF | 0 | 0 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.86 | -0.875 | 0.0358489B | -0.7% | -2.54M |
| FQ2 2025 (Jun 2025) | -0.64 | -0.64 | 0.0309983B | 5.25% | -1.66M |
| FQ1 2025 (Mar 2025) | -0.07 | -0.07 | 0.0332125B | 7.4% | 0.96M |
| FQ4 2024 (Dec 2024) | -0.042 | -0.042 | 0.0355944B | 13.03% | 2.5M |
| FQ3 2024 (Sep 2024) | -0.0575 | -0.0875 | 0.0360992B | 17.08% | 5.41M |
| FQ2 2024 (Jun 2024) | 0.0171 | -0.0129 | 0.0293709B | 100% | -1.27M |
| FQ1 2020 (Mar 2020) | 0 | 0 | 0.0317139B | 100% | 31.71M |
| FQ2 2020 (Jun 2020) | 0 | 0 | 0.0317139B | 100% | 31.71M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
-0.345
Consensus Revenue Estimates
0.034298B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | -0.115 | -- | -0.11688 | -0.11312 | 1 |
| FQ3 2026 (Sep 2026) | 0.01 | 8700 | 0.00983653 | 0.01016347 | 1 |
| FQ2 2026 (Jun 2026) | -0.08 | -700 | -0.08130773 | -0.07869227 | 1 |
| FQ1 2026 (Mar 2026) | -0.345 | 79.71 | -0.35064 | -0.33936 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 0.04B | -- | 0.04B | 0.04B | 1 |
| FQ3 2026 (Sep 2026) | 0.04B | 4.14 | 0.04B | 0.04B | 1 |
| FQ2 2026 (Jun 2026) | 0.03B | 9.08 | 0.03B | 0.03B | 1 |
| FQ1 2026 (Mar 2026) | 0.03B | 3.16 | 0.03B | 0.03B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
0
EPS # of Misses
6
EPS # of in-lines
2
Revenue # of Beats
5
Revenue # of Misses
3
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.015 | -0.86 | -0.875 | 101.74% |
| FQ2 2025 (Jun 2025) | 0 | -0.64 | -0.64 | 100% |
| FQ1 2025 (Mar 2025) | 0 | -0.07 | -0.07 | 100% |
| FQ4 2024 (Dec 2024) | 0 | -0.042 | -0.042 | 100% |
| FQ3 2024 (Sep 2024) | 0.03 | -0.0575 | -0.0875 | 152.17% |
| FQ2 2024 (Jun 2024) | 0.03 | 0.0171 | -0.0129 | -75.44% |
| FQ1 2020 (Mar 2020) | 0 | 0 | NAN% | |
| FQ2 2020 (Jun 2020) | 0 | 0 | NAN% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.04B | $0.04B | $-2.54M | -7.09% |
| FQ2 2025 (Jun 2025) | $0.03B | $0.03B | $-1.66M | -5.35% |
| FQ1 2025 (Mar 2025) | $0.03B | $0.03B | $0.96M | 2.89% |
| FQ4 2024 (Dec 2024) | $0.03B | $0.04B | $2.5M | 7.03% |
| FQ3 2024 (Sep 2024) | $0.03B | $0.04B | $5.41M | 15% |
| FQ2 2024 (Jun 2024) | $0.03B | $0.03B | $-1.27M | -4.31% |
| FQ1 2020 (Mar 2020) | $0B | $0.03B | $31.71M | 100% |
| FQ2 2020 (Jun 2020) | $0B | $0.03B | $31.71M | 100% |